Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2826_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
09.09.2026
Размер:
18 Мб
Скачать
Therapeutics 343
therapy or hyperaldosteronism. Vomiting causes alkalosis, both by causing volume depletion and through loss of gastric acid.
Clinical features
Cerebral dysfunction is an early feature of alkalosis. Respiration may be depressed.
Management
This includes fluid replacement, if necessary, with replacement of sodium, potassium and chloride. The bicarbonate excess will correct itself.

THERAPEUTICS

Diuretics

Diuretics (see Table 8.4) reduce sodium and chloride reabsorption at different sites in the nephron and thus increase urinary sodium and water loss.
Thiazide diuretics
Examples
Bendroflumethiazide, metolazone.
Mechanism of action
They inhibit sodium reabsorption at the beginning of the distal convoluted tubule and reduce peripheral vascular resistance.
Indications
In low doses, they are used to reduce blood pressure; at higher doses, to relieve oedema in patients with mild chronic heart failure and good renal function.
Side effects
Postural hypotension, anorexia, diarrhoea, metabolic and electrolyte distur­bances (hyponatraemia, hypokalaemia, hypomagnesaemia, hypercalcaemia, hyperuricaemia and gout). May aggravate diabetes mellitus.
Loop diuretics
Examples
Furosemide, bumetanide.
Mechanism of action
Loop diuretics stimulate excretion of sodium chloride and water by blocking the sodium–potassium–chloride channel in the thick ascending limb of the loop of Henle. Loop diuretics also increase venous capacitance and thus
344 Water, electrolytes and acid–base balance
produce rapid clinical improvement before the diuresis in patients with acute heart failure.
Indications
Loop diuretics are given intravenously in patients with acute pulmonary oedema due to left heart failure. They are administered orally in patients with chronic heart failure and in patients with oedema associated with liver disease if aldosterone antagonists alone are ineffective. High doses may be needed with impaired renal function.
Side effects
Metabolic disturbance (hypokalaemia, hypomagnesaemia, hyponatraemia, hyperuricaemia causing gout, hyperglycaemia) tinnitus and deafness with rapid i.v. administration or high doses.
Potassium-sparing diuretics and aldosterone antagonists
Examples
Spironolactone, amiloride.
Mechanism of action
Potassium-sparing diuretics and aldosterone antagonists inhibit sodium reabsorption in the cortical collecting tubule. Amiloride and triamterene directly decrease sodium channel activity; spironolactone inhibits aldoste­rone. They have weak natriuretic activity.
Indications
Spironolactone is used in ascites and oedema associated with chronic liver disease and in low doses to improve survival in severe heart failure. Amiloride in combination with loop diuretics can be used as an alternative to giving potassium supplements. Amiloride may be used in patients with liver disease who are intolerant of spironolactone because of gynaecomastia.
Side effects
Hyperkalaemia, gynaecomastia, acute kidney injury.
9
The kidneys are 11–14 cm in length and lie retroperitoneally on either side of the vertebral column from T12–L3. The functions of the kidneys are:
• Elimination of waste material
• Regulation of volume and composition of body fluid
• Endocrine function – production of erythropoietin, renin and vitamin D in
its active form
• Autocrine function – production of endothelin, prostaglandins, renal
natriuretic peptide.
The functional unit of the kidney is the nephron, of which there are about 1 million in each kidney. Each nephron is composed of a glomerulus, proximal tubule, loop of Henle, distal tubule and collecting duct (Fig. 9.1). The renal artery (a branch of the abdominal aorta) supplies the kidney and divides many times to form afferent arterioles, which supply the glomerular capillary tuft before draining into efferent arterioles. Efferent arterioles from (outer) cortical glomeruli drain into a peritubular capillary network within the renal cortex and then into increasingly larger branches of the renal vein. By contrast, blood from the (inner) juxtamedullary glomeruli passes via vasa recta in the medulla and returns via the cortex to renal veins that drain into the inferior vena cava. The wider diameter of the afferent compared to efferent arterioles increases the pressure of blood within the glomerulus and forces water and solutes (but not red blood cells or larger molecular weight plasma proteins) out of the glomerular capillaries into the Bowman’s capsule, forming the glomerular filtrate (about 170–180 L per day). The proximal renal tubules reabsorb most of the filtered solute required to maintain fluid and electrolyte balance, but elimination of potassium, water and non-volatile hydrogen ions is regulated in the distal tubules. As renal perfusion and glomerular filtration fall, reabsorption of water and sodium by the proximal tubules increases so that minimal fluid reaches the distal tubule. Hence, hypotensive or hypovolaemic patients cannot excrete potassium and hydrogen ions. Patients with distal tubular damage, e.g. caused by drugs, also cannot excrete potassium and hydrogen ions. Normally only about 1% of the original filtered volume, containing high concentrations of urea and creatinine, passes into the renal pelvis as urine.

Renal disease

PRESENTING FEATURES OF RENAL DISEASE

The most common diseases of the kidney and urinary tract are benign prostatic hypertrophy in men and urinary tract infections (UTIs) in women.
346 Renal disease
Filtered blood
Afferent
Glomerulus (‘capillary bed’=
Loop of Henle
Waste products
(urine)
to the bladder
Fig. 9.1 The kidney and a nephron.
Renal vein draining to inferior vena cava
Blood with waste products
Renal artery
Ureter
arteriole
network of blood capillaries)
Efferent arteriole
Bowman’s capsule
Proximal convoluted
tubule (PCT)
Renal cortex
Renal medulla
Descending
limb of Henle
Vasa recta
Distal convoluted
tubule (DCT)
Collecting duct (leading to the pelvis of the kidney, also known as the ‘renal pelvis’)
Ascending limb of Henle
Presenting Features of Renal Disease 347
Symptoms suggesting renal tract disease are dysuria, frequency of micturi­tion, haematuria, urinary retention and alteration of urine volume (either polyuria or oliguria). In addition there may be pain anywhere along the renal tract, from loin to groin. Non-specific symptoms, e.g. lethargy, anorexia and pruritus, may be the presenting features of chronic kidney disease (CKD). Renal disease may be asymptomatic and discovered by an incidental finding of hypertension, a raised serum urea, or proteinuria and haematuria on urine dipstick testing.

Dysuria

Dysuria (pain on micturition) is caused by:
• Inflammation involving the urethra (urethritis) or bladder (cystitis). Dysuria
is common in adult women and is usually due to lower urinary tract bacterial infection (p. 362). Other causes of urethritis include infection with Chlamydia trachomatis or Neisseria gonorrhoeae (pp. 45–46).
• Inflammation involving the vagina in women or glans penis in men.
Causes include infection with Candida albicans and Gardnerella vaginalis.

Polyuria and nocturia

Polyuria is an excessive urine output of greater than 2.5–3 L in 24 hours. It must be differentiated from the more common complaints of urinary frequency and nocturia (night-time urination), which are not necessarily associated with an increase in the total urine output. Causes of polyuria include polydipsia (defined as excessive thirst leading to increased fluid intake >3 L per day), solute diuresis (e.g. hyperglycaemia with glycosuria), diabetes insipidus and CKD. Nocturia is most often due to drinking before bed or, in men over 50 years, prostatic enlargement (p. 394).

Oliguria

Oliguria describes a low urine output. If maintained over several hours this indicates acute kidney injury (AKI, p. 375) or urinary tract obstruction. It may be ‘physiological’, as in patients with hypotension and hypovolaemia, where urine is maximally concentrated in an attempt to conserve water. Anuria (no urine) suggests bilateral ureteric or bladder outflow obstruction. Management of the oliguric patient involves three steps:
1. Exclude obstruction. The patient with outflow obstruction (acute urinary
retention) is typically in great discomfort with an intense desire to micturate. The bladder is palpable as a tender mass arising out of the pelvis that is dull to percussion. The diagnosis is confirmed by passing a
348 Renal disease
urethral catheter and releasing a large volume of urine. If the patient is already catheterized, the catheter should be flushed with sterile saline to relieve any blockage. Obstruction proximal to the bladder (e.g. ureteric obstruction) is often painless. Ultrasound examination is indicated to exclude pelvicalyceal dilatation.
2. Assess for hypovolaemia. Once obstruction has been excluded,
the patient should be assessed for evidence of hypovolaemia by measurement of blood pressure, pulse, jugular venous pressure (JVP) and urinary electrolytes (p. 349). If the patient is hypovolaemic, the urine output in response to a fluid challenge is assessed.
3. Management of established AKI. (p. 380) Once obstruction and
hypovolaemia have been excluded, management should focus on treating the AKI and correcting any underlying cause where appropriate.

Haematuria

See urine dipstick testing (p. 351).

Pain

Loin/flank pain occurs in kidney infections (acute pyelonephritis), upper urinary tract obstruction and occlusion of the renal artery due to either throm­bosis in situ or emboli. Chronic renal pain occurs in cystic renal disease and renal tumours. Acute severe pain radiating from the flank to the iliac fossa and testes or labium is typical of ureteric colic due to a calculus.

INVESTIGATION OF RENAL DISEASE

Once renal disease is suspected, the purpose of investigation is to deter­mine the cause and the presence or degree of renal dysfunction. The estimated glomerular filtration rate (eGFR, see below) is used to determine the degree of renal dysfunction. The history and examination together with urine dipstick testing and microscopy of urine are the starting points for diagnosis.

Blood tests

The serum urea or creatinine concentration represents the dynamic equi­librium between production and elimination but levels do not rise above the normal range until there is a reduction of 50%–60% in the glomerular filtration rate (GFR). The serum urea concentration may be increased by a high-protein diet, increased tissue catabolism (surgery, trauma, infec­tion), and gastrointestinal bleeding, whereas the level of creatinine is less
Investigation of Renal Disease 349
()
()
dependent on diet but more related to age, gender and muscle mass. Once elevated, serum creatinine is a better guide to GFR than urea, although a normal level is not synonymous with a normal GFR.

Glomerular filtration rate

Measurement of the GFR is the best indicator of kidney function. Daily production of creatinine (primarily from muscle cells) is fairly constant and generally unaffected by protein intake. Serum creatinine and excreted (uri­nary) creatinine vary little throughout the day, allowing measurement of the creatinine clearance. It is calculated using a 24-hour urine collection and a single plasma creatinine. However, measurement of GFR is cumbersome and time-consuming, and may be inaccurate if 24-hour urine collections are incomplete. Several formulae have been developed to predict creatinine clearance or GFR based on serum creatinine and patient characteristics including age, weight, gender and ethnicity (e.g. the Cockroft–Gault equation, the modification of diet in renal disease (MDRD) equation and the CKD­epidemiology (CKD-EPI) collaboration equation).
Calculation of creatinine clearance using the Cockroft–Gault equation
Men
Creatinine clearance
Women. Use the same equation but multiply by 1.04 instead of 1.23.
These equations have not been fully validated across all ranges of renal impairment, weights or body mass index (BMI), or in all ethnic groups. However, for monitoring patients with acute or chronic kidney disease, the convenience and ease of the eGFR has led to its widespread adoption.
1.23 140 AgeWeight in kg
=
××()
Serum cr
eeatininemol /L
µ

Urine dipstick testing

Urine dipstick testing detects the presence of blood, protein, glucose, ketones, bilirubin and urobilinogen in the urine and provides a semiquantita­tive assessment of the amount of substance present. Dipsticks can also be used to measure urine pH, which is useful in the investigation and manage­ment of renal tubular acidosis (p. 343). Each test is based on a colour change in a strip of absorbent cellulose impregnated with the appropriate reagent. The stick is dipped briefly into a fresh specimen of urine collected in a clean container and the colour changes compared with the manufacturer’s colour charts on the reagent strip container. Haematuria or proteinuria suggests renal tract disease. Dipsticks are also available for testing for urinary nitrites and leucocyte elastase to identify UTIs (p. 362).
350 Renal disease
Proteinuria
This is an excess of protein in the urine. Under normal conditions the low molecular weight proteins and albumin that are filtered by the glomerulus are almost completely reabsorbed in the proximal renal tubule. This results in a normal urinary protein excretion of less than 150 mg/day, of which only a small amount is albumin (<30 mg daily). Dipsticks are albumin specific and will detect albumin once urine levels exceed 200 mg/L (300 mg daily if urine volume is normal). Dipsticks do not detect abnormal proteins such as globulins and Bence Jones protein (immunoglobulin light chains) excreted in multiple myeloma. The causes of proteinuria are listed in Table 9.1. Persistent proteinuria detected on dipstick testing requires full investigation and should be quantified. Quantification of proteinuria is by measurement of protein and/or albumin concentration in a ‘spot’ urine sample (ideally an early morning specimen) and normalizing to creatinine concentration to give a urine protein-to-creatinine ratio (PCR) or the more sensitive urine albumin­to-creatinine ratio (ACR). Normal protein excretion is less than 150 mg per day (PCR <15 mg/mmol) and nephrotic range proteinuria (p. 357) is more than 3.5 g per day (PCR >350 mg/mmol).
Table 9.1 Causes of proteinuria
Type Mechanism Examples
Glomerular Increased permeability Glomerulopathies
Tubular*
Overflow
Decreased reabsorption
Plasma proteins produced in excess
Physiological
Increased renal haemodynamics
*Usually <1 g per day and may be associated with other defects of proximal tubular
function (e.g. glucosuria, phosphaturia, aminoaciduria).
†Mild proteinuria and not associated with underlying renal disease. Diagnosis is made
by the absence of proteinuria on subsequent urine examinations when the condition, e.g.
fever, resolves.
Fanconi’s syndrome
Tubulointerstitial disorders
Multiple myeloma
Monoclonal gammopathy
Acute illness
Fever
Intense activity
Upright posture
Investigation of Renal Disease 351
Infarct
Stone
Stone
Parasites
Tubulo­interstitial nephritis
Papillary necrosis
Tumour
Ureteric neoplasms
Bleeding disorders
Microalbuminuria is an increase above the normal range in urinary albumin excretion that is undetectable by conventional dipsticks (i.e. 30–300 mg/day). It is an early indicator of renal disease and is widely used as a predictor of the development of nephropathy in people with diabetes. An ACR of >2.5 mg/mmol in men and >3.5 mg/mmol in women indicates microalbuminuria. Albumin excretion above 300 mg/day is overt proteinuria.
Haematuria
Haematuria is blood in the urine and is either visible (macroscopic or gross) or non-visible (microscopic).
Haematuria can arise from several sites in the kidney or urinary tract (Fig. 9.2).
• Blood that is only apparent at the start of micturition is usually due to
urethral disease
• Blood at the end of micturition suggests bleeding from the prostate or
bladder base
• Blood seen as an even discoloration throughout the urine suggests
bleeding from a source in the bladder or above.
Trauma
Cysts
Tuberculosis
Glomerulonephritis
Single Multiple
Urethra
Trauma Infection
Fig. 9.2 Sites and causes of bleeding from the urinary tract.
Carcinoma
or stones
Carcinoma or papilloma
Infection
Prostate
Benign hypertrophy Carcinoma
352 Renal disease
Haematuria
Exclude transient causes
Visible haematuria Non-visible haematuria
Plasma Cr for eGFR
Urology assessment
Renal tract imaging
+ cystoscopy
Fig. 9.3 Decision algorithm for the investigation of haematuria. Cr, creatinine; eGFR,
estimated glomerular filtration rate; ACR (PCR), albumin (protein):creatinine ratio.
Plasma Cr for eGFR
Urine for ACR or PCR
Age 40 years or
Symptomatic
Normal
investigations
Repeat yearly Nephrology referral
All
others
Abnormal
investigations
Fig. 9.3 outlines an algorithm for the investigation of haematuria. Patients
should be evaluated regardless of anticoagulant or antiplatelet therapy. Transient causes such as urinary tract infection and contamination during menstruation should be excluded by repeat testing. Urinary tract malignancy is more likely in patients with visible haematuria, urinary tract symptoms or those over 40 years of age. Urological referral should be considered for appropriate imaging of the urinary tract (either ultrasound or computed tomography [CT]) and cystoscopy. All other patients are more likely to have glomerular disease (often immunoglobulin [Ig]A nephropathy) and nephrology referral is indicated if initial or subsequent testing of renal function is abnormal.
Glycosuria
Diabetes mellitus must be excluded in any patients with a positive dipstick test for glucose.

Urine microscopy

This is performed on a fresh, clean-catch, mid-stream urine specimen in all patients suspected of having renal disease.